Outcome map · Supplement

Cognition in dementia: what the evidence supports

2 graded interventions for cognition in dementia, ranked by strength of evidence.

Overall grade
Grade C
Last revised
2
graded outcomes
0
references listed

Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.

2 at grade C — 2 graded rows

What is known

Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.

  • Huperzine AEvidence grade C

    Variable-quality trials

    Smallmixed

  • SageEvidence grade C

    Preliminary

    Smalllow

What is uncertain

Read off the same rows as above. Nothing here is added that the entry does not itself record.

  • Thin evidence: Huperzine A (grade C); Sage (grade C).

The evidence in words

The evidence map

This is the ranked evidence for cognition in dementia: every compound in the knowledge base with a graded effect, best-supported first. Grades reflect replication and effect size, not popularity or marketing.

Best-supported

No intervention here reaches grade A or B — an honest reflection of how thin the evidence for cognition in dementia still is.

Weaker or unproven

Huperzine A (grade C) — Variable-quality trials · Sage (grade C) — Preliminary

Goes with

Entries that share this one's tags or conditions.

Sources

This entry lists no references of its own — it is assembled from the entries it links to, whose sources are on their pages.

Last revised . A grade is this entry's reading of the evidence, not medical advice.